Sale!

Leukemia Genetic Profile – Any 6 Markers PCR Qualitative Test Cost

Original price was: 1,720 د.إ.Current price is: 1,550 د.إ.

-10%

The “Leukemia Genetic Profile – Any 6 Markers PCR Qualitative Test” is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify specific genetic markers associated with various types of leukemia. This test employs the Polymerase Chain Reaction (PCR) method, a highly sensitive and precise technique for amplifying and detecting DNA sequences. By focusing on any six genetic markers, this test provides crucial information that can help in the diagnosis, prognosis, and in some cases, the selection of targeted therapies for individuals with leukemia. The selection of markers is typically based on the most relevant genetic mutations associated with the patient’s specific type of leukemia. The cost of this comprehensive and qualitative test is 1550 AED. This test is pivotal for healthcare providers in making informed decisions regarding patient care and treatment plans, offering a personalized approach to leukemia management. DNA Labs UAE is renowned for its state-of-the-art facilities and expertise in genetic testing, ensuring reliable and accurate results for patients and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

LEUKEMIA GENETIC PROFILE – ANY 6 MARKERS PCR QUALITATIVE Test

Test Details:

A PCR qualitative test for leukemia genetic profiling may include the following six markers:

  1. BCR-ABL fusion gene: This marker is commonly found in chronic myeloid leukemia (CML) and is caused by a translocation between chromosomes 9 and 22. It leads to the production of an abnormal protein that promotes uncontrolled cell growth.
  2. FLT3 gene mutation: This marker is frequently found in acute myeloid leukemia (AML). Mutations in the FLT3 gene can lead to the overactivation of a protein that promotes cell division and survival.
  3. NPM1 gene mutation: NPM1 mutations are also commonly found in AML. These mutations can lead to the abnormal localization of a protein involved in cell growth and division.
  4. TP53 gene mutation: TP53 mutations are associated with various types of leukemia, including chronic lymphocytic leukemia (CLL) and AML. TP53 is a tumor suppressor gene, and mutations can lead to the uncontrolled growth of cancer cells.
  5. TET2 gene mutation: TET2 mutations are frequently found in myelodysplastic syndromes (MDS) and other myeloid malignancies. TET2 is involved in the regulation of gene expression, and mutations can lead to abnormal cell growth and differentiation.
  6. JAK2 gene mutation: JAK2 mutations are commonly found in myeloproliferative neoplasms (MPNs), such as polycythemia vera and essential thrombocythemia. JAK2 is involved in signaling pathways that regulate blood cell production, and mutations can lead to the overproduction of blood cells.

These markers can be detected using PCR (polymerase chain reaction) techniques to amplify specific DNA sequences and determine the presence or absence of genetic abnormalities associated with leukemia. The qualitative nature of the test means it can provide a “yes” or “no” answer regarding the presence of specific genetic markers.

Test Name: LEUKEMIA GENETIC PROFILE – ANY 6 MARKERS PCR QUALITATIVE Test

Components:

Any 6 of the following markers can be selected:

  • AML: BCR-ABL, PML-RARA, AML-ETO, INV16, NPM1, FLT3
  • ALL: BCR-ABL, MLL-AF9, MLL-AF4, MLL-ENL,t(12;21),t(1;19)

Price: 1550.0 AED

Sample Condition:

3 mL (2 mL min.) whole blood / Bone Marrow Aspirate in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Specify the 6 markers selected on Test Request Form. Give brief clinical history.

Report Delivery:

Sample Tue / Fri by 11 am; Report Thu / Mon

Method: Real Time PCR

Test Type: Leukemias

Doctor: Oncologist, Hematologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information:

Give brief clinical history.

Test Name LEUKEMIA GENETIC PROFILE – ANY 6 MARKERS PCR QUALITATIVE Test
Components Any 6 of the following markers can be selected: AML: BCR-ABL, PML-RARA, AML-ETO, INV16, NPM1, FLT3 ALL: BCR-ABL, MLL-AF9, MLL-AF4, MLL-ENL,t(12;21),t(1;19)
Price 1550.0 AED
Sample Condition 3 mL (2 mL min.) whole blood \/ Bone Marrow Aspirate in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Specify the 6 markers selected on Test Request Form. Give brief clinical history.
Report Delivery Sample Tue / Fri by 11 am; Report Thu / Mon
Method Real Time PCR
Test type Leukemias
Doctor Oncologist, Hematologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Give brief clinical history.
Test Details

A PCR qualitative test for leukemia genetic profiling may include the following six markers:

1. BCR-ABL fusion gene: This marker is commonly found in chronic myeloid leukemia (CML) and is caused by a translocation between chromosomes 9 and 22. It leads to the production of an abnormal protein that promotes uncontrolled cell growth.

2. FLT3 gene mutation: This marker is frequently found in acute myeloid leukemia (AML). Mutations in the FLT3 gene can lead to the overactivation of a protein that promotes cell division and survival.

3. NPM1 gene mutation: NPM1 mutations are also commonly found in AML. These mutations can lead to the abnormal localization of a protein involved in cell growth and division.

4. TP53 gene mutation: TP53 mutations are associated with various types of leukemia, including chronic lymphocytic leukemia (CLL) and AML. TP53 is a tumor suppressor gene, and mutations can lead to the uncontrolled growth of cancer cells.

5. TET2 gene mutation: TET2 mutations are frequently found in myelodysplastic syndromes (MDS) and other myeloid malignancies. TET2 is involved in the regulation of gene expression, and mutations can lead to abnormal cell growth and differentiation.

6. JAK2 gene mutation: JAK2 mutations are commonly found in myeloproliferative neoplasms (MPNs), such as polycythemia vera and essential thrombocythemia. JAK2 is involved in signaling pathways that regulate blood cell production, and mutations can lead to the overproduction of blood cells.

These markers can be detected using PCR (polymerase chain reaction) techniques to amplify specific DNA sequences and determine the presence or absence of genetic abnormalities associated with leukemia. The qualitative nature of the test means it can provide a “yes” or “no” answer regarding the presence of specific genetic markers.